PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
1.17M
No peer data available for comparison.
-234.73K
No peer data available for comparison.
-1.16
No peer data available for comparison.
-30.77M
No peer data available for comparison.
-234.73K
No peer data available for comparison.
43.49M
No peer data available for comparison.
Analyze DCF forecasts for the company and compare them with competitors.
No Data
No DCF data available for this metric in the selected year.
-50.53%
Worse than KOD's revenue growth rate of 0.00%.
No Data
No DCF data available for this metric in the selected year.
-20.00%
Worse than KOD's ebitda margin of 100.00%.
No Data
No DCF data available for this metric in the selected year.
-20.00%
Worse than KOD's ebit margin of 100.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
100.00%
Equal to KOD's cash as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
40.00%
Better than KOD's receivables as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
40.00%
Better than KOD's inventories as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Equal to KOD's payables as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
-29.43%
Better than KOD's capex as percentage of revenue of 0.00%.
4.99%
Better than KOD's weighted average cost of capital (wacc) of 12.34%.
5.02%
Better than KOD's cost of equity of 15.51%.
4.08%
Worse than KOD's cost of debt of 4.06%.
-0.23
Better than KOD's beta of 2.43.
30.07M
Better than KOD's diluted shares outstanding of 52.58M.
1.57M
Better than KOD's total debt of 70.34M.
49.31M
Worse than KOD's total equity of 184.04M.
50.89M
Worse than KOD's total capital of 254.39M.
3.09%
Better than KOD's debt weighting of 27.65%.
96.91%
Better than KOD's equity weighting of 72.35%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
2.00%
Equal to KOD's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Worse than KOD's net debt of -97.73M.
71.33M
Worse than KOD's equity value of 94.24M.
2.37
Better than KOD's equity value per share of 1.79.